Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 | Link | |
MCF10A-Rad6B |
Human breast fibrocystic disease cell line, stably expressing Rad6B | Human | breast | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | U. K. Mukhopadhyay et al., Cancer Res., Apr 2005; 65: 2872 - 2881 | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | R. Malaguarnera et al., Endocrinology, 2014, 155(4): 1207-1221, doi: 10.1210/en.2013-1925 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | H. Brennenstuhl et al., Int. J. of Oncology, 2015, 47: 1971-1980; DOI: 10.3892/ijo.2015.3159 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Happold et al., Mol. Cancer Ther., Apr 2014; 13: 948 - 961 | Link | |
LN-18 |
Human brain glioblastoma cell line | ATCC CRL-2610 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
LN-18 |
Human brain glioblastoma cell line | ATCC CRL-2610 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | C. Happold et al., Mol. Cancer Ther., Apr 2014; 13: 948 - 961 | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | Y.-L. Wang et al., World J. Gastroenterol., 2014, 20(47): 17924-17931, DOI: 10.3748/wjg.v20.i47.17924 | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | J. Galán‐Martínez et al., Mol. Oncology, 2021, doi:10.1002/1878-0261.13085 | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | K. Stamatakis et al., Oncotarget, Advance Publications 2015; DOI: 10.18632/oncotarget.5402 | ||
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | M. Zhang et al., JBUON, 2015, 20(1): 121 | Link | |
HSC-T6 |
Rat liver stellate cell line | Rat | digestive organs | cell line | plasmid | RNA-Interference | Metafectene | publication | R. Fu et al., Experimental Biology and Medicine, Mar 2011; 236: 291 - 297 | ||||
hMSC |
Human primary mesenchymal stem cells | Human | unknown | stem cell | adherent | plasmid | RNA-Interference | Metafectene | publication | J. Cheng et al., Wei Sheng Yan Jiu, Sep 2006; 35(5): 564-6. | |||
HMEC-1 |
Human dermal microvascular endothelial cells | ATCC CRL-3243 | Human | vasculature | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | D. Flügel et al., Blood, 2012, 119(5):1292‐1301, doi:10.1182/blood-2011-08-375014 | Link | |
hLEC |
Human lens epithelial cell line | Human | sensory organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | Y. Su et al., Molecular Vision, 2012, 18: 601-605 | Link | ||
HKe-3 |
Human colon carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Yi Xue Za Zhi, Sep 2005; 85(35): 2503-6 | |||
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Gan Zang Bing Za Zhi, Sep 2004; 12(9): 522-5 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M.I. Koukourakis et al., Scientific Reports, 2016, 6:30986; DOI: 10.1038/srep30986 | Link | |
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | H. Chi et al., Lin Chuang Er Bi Yan Hou Ke Za Zhi, Nov 2005; 19(21): 992-5 | ||
HeLa-DR-13–9 |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | B. Haynesa et al., Biochim Biophys Acta Mol Basis Dis., 2020,1866(1): 165561, doi:10.1016/j.bbadis | Link |